跳至主要内容
临床试验/NCT05973721
NCT05973721招募中不适用

To Investigate the Clinical Efficacy and Safety of Phage Therapy for Chronic Constipation

Shanghai 10th People's Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
To observe the curative effect of PIB phage on refractory constipation by defecation behavior of patients.

研究概览

简要总结

The overall aim was to evaluate the efficacy of PiB-specific phages for the treatment of refractory constipation through clinical studies, primarily for the publication of scientific papers and to guide the development of phage therapies. The purpose of this study will be subdivided into three aspects from three aspects: target exposure level, target occupation, and functional effects after acting on the target, including:1) The distribution of PIB phage in the intestine of patients with refractory constipation;2) The killing effect of PIB phage on PIB bacteria in refractory constipation patients;And 3) therapeutic effect of PIB phage on patients with refractory constipation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of both sexes, aged 18-70 years, with confirmed chronic constipation and positive fecal bacteria test for PIB, agreed to participate in this experiment and signed an informed consent.

排除标准

  • Severe heart failure, hypertension, cerebrovascular disease (e.g. stroke, moyamoya disease, etc.); Secondary constipation caused by psychotropic drug abuse; Pregnant or lactating women.

结局指标

主要结局

To observe the curative effect of PIB phage on refractory constipation by defecation behavior of patients.

时间窗: Baseline and six months after treatment

Defecation behavior: A questionnaire was designed according to Rome IV criteria, and the questionnaire was collected and recorded, including the number of spontaneous bowel movements per week, PAC-QoL score, PAC-SYM score and Bristol stool trait score

The concentration of phage in feces was detected to evaluate the survival and survival ratio of active phage in the intestinal tract of patients.

时间窗: Baseline and 24-48 hours after phage administration (first bowel movement)

Real-time PCR was used to detect the nucleic acid of PIB bacteria and HPLC was used to detect the distribution of fecal PIB phage in the intestinal tract of patients with refractory constipation

时间窗: Baseline and two weeks after treatment

次要结局

未报告次要终点

研究者

发起方
Shanghai 10th People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Huanlong Qin

Clinical Professor

Shanghai 10th People's Hospital

研究点 (1)

Loading locations...

相似试验